Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hereditary elliptocytosis in which the cause of the disease is a mutation in the SPTA1 gene.
Features include: Elliptocytosis, Neonatal hyperbilirubinemia, Red blood cell destruction (hemolytic anemia), and Increased immature red blood cells (reticulocytosis).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Red blood cell destruction (hemolytic anemia), Increased immature red blood cells (reticulocytosis) |
SPTA1 function has not been fully characterized.
Elliptocytosis 2 is associated with mutations in the SPTA1 gene on chromosome 1.
Genetic testing for SPTA1 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for elliptocytosis 2.
12 publications have been identified in PubMed for elliptocytosis 2. Research spans Case Report / Case Series (75%), Epidemiology / Natural History (17%), and Basic Science / Preclinical (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 75% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:31 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Lab test results
1 |
Neonatal hyperbilirubinemia |
Pregnancy and birth | 1 | Neonatal hyperbilirubinemia |
Age of onset: newborn period.
2 |
17% |
Laboratory research | 1 | 8% |
Maneekesorn S (2026). [PMID: 42136044](https://pubmed.ncbi.nlm.nih.gov/42136044/). *Br J Haematol*. [Basic Science / Preclinical]
Melo MAW (2026). [PMID: 41467246](https://pubmed.ncbi.nlm.nih.gov/41467246/). *International journal of laboratory hematology*. [Case Report / Case Series]
Ciurej A (2026). [PMID: 41925069](https://pubmed.ncbi.nlm.nih.gov/41925069/). *Pediatric blood & cancer*. [Case Report / Case Series]
Komvilaisak P (2026). [PMID: 41840148](https://pubmed.ncbi.nlm.nih.gov/41840148/). *Journal of perinatology : official journal of the California Perinatal Association*. [Epidemiology / Natural History]
Chakraborty A (2026). [PMID: 42054241](https://pubmed.ncbi.nlm.nih.gov/42054241/). *J Pediatr Hematol Oncol*. [Epidemiology / Natural History]
Alamr F (2025). [PMID: 41020088](https://pubmed.ncbi.nlm.nih.gov/41020088/). *Journal of medicine and life*. [Case Report / Case Series]
Molina-Arrebola MA (2025). [PMID: 40530495](https://pubmed.ncbi.nlm.nih.gov/40530495/). *American journal of hematology*. [Case Report / Case Series]
Sayed J (2025). [PMID: 41098499](https://pubmed.ncbi.nlm.nih.gov/41098499/). *International medical case reports journal*. [Case Report / Case Series]
Dar A (2024). [PMID: 38108326](https://pubmed.ncbi.nlm.nih.gov/38108326/). *Fetal and pediatric pathology*. [Case Report / Case Series]
Jiang S (2024). [PMID: 39502561](https://pubmed.ncbi.nlm.nih.gov/39502561/). *Frontiers in pediatrics*. [Case Report / Case Series]